Education
About Us
Working with TipRanks
Follow Us
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.26B | $ 2.35B | $ 2.24B | $ 2.29B | $ 2.12B |
| Gross Profit | $ 2.26B | $ 2.35B | $ 2.24B | $ 2.29B | $ 1.89B |
| Operating Income | $ 1.29B | $ 1.49B | $ 307.06M | $ 1.43B | $ 1.60B |
| EBITDA | $ 1.56B | $ 1.89B | $ 423.69M | $ 1.43B | $ 1.68B |
| Net Income | $ 858.98M | $ 1.13B | $ 42.83M | $ 619.73M | $ 975.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.77B | $ 1.23B | $ 2.43B | $ 2.80B | $ 2.65B |
| Total Assets | $ 18.22B | $ 16.38B | $ 16.81B | $ 17.52B | $ 16.02B |
| Total Debt | $ 7.61B | $ 6.14B | $ 7.12B | $ 7.10B | $ 5.82B |
| Net Debt | $ 6.68B | $ 5.66B | $ 5.41B | $ 5.56B | $ 4.81B |
| Total Liabilities | $ 7.88B | $ 6.30B | $ 7.29B | $ 7.27B | $ 6.12B |
| Stockholders' Equity | $ 6.95B | $ 6.53B | $ 5.63B | $ 5.78B | $ 4.82B |
| Cash Flow | |||||
| Free Cash Flow | $ 2.77B | $ 2.99B | $ 2.14B | $ 2.02B | $ 2.03B |
| Operating Cash Flow | $ 2.77B | $ 2.99B | $ 2.14B | $ 2.02B | $ 2.03B |
| Investing Cash Flow | $ -2.68B | $ -2.07B | $ -1.03B | $ -1.87B | $ -2.76B |
| Financing Cash Flow | $ 361.14M | $ -2.15B | $ -944.86M | $ 385.11M | $ 1.49B |